Publicacións (114) Publicacións de Raúl De la Fuente Fernández

2015

  1. Factors contributing to caregivers' stress and burden in Parkinson's disease

    Acta Neurologica Scandinavica, Vol. 131, Núm. 4, pp. 203-210

  2. Síndrome de anton secundario a necrosis occipital por intoxicación aguda con metanol

    Revista de Neurologia

2014

  1. DaTscan and Parkinson's disease: DAT binding should not lead to binding decisions in clinical practice

    European Journal of Neurology

  2. Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease

    Revista de Neurologia, Vol. 58, Núm. 11, pp. 505-515

  3. Neuroimagen funcional en el diagnóstico de pacientes con síndrome parkinsoniano: Actualización y recomendaciones para el uso clínico

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 33, Núm. 4, pp. 215-226

  4. Role of teleneurology in health and social care centres

    European journal of clinical pharmacy: atención farmacéutica, Vol. 16, Núm. 5, pp. 5-5

2013

  1. A predictive model of neurodegeneration in idiopathic REM-sleep behavior disorder

    Parkinsonism and Related Disorders, Vol. 19, Núm. 11, pp. 1009-1012

  2. Carotid bifurcation (T) hypodense in stroke: The 'sign of the tree'

    Revista de Neurologia

  3. Imaging of dopamine in PD and implications for motor and neuropsychiatric manifestations of PD

    Frontiers in Neurology, Vol. 4 JUL

  4. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease

    Journal of the Neurological Sciences, Vol. 332, Núm. 1-2, pp. 136-140

  5. Impact of non-motor symptoms on the quality of life of patients with Parkinsons disease: Some questions beyond research findings

    Journal of the Neurological Sciences

  6. Impact of placebo assignment in clinical trials of tic disorders

    Movement Disorders, Vol. 28, Núm. 9, pp. 1288-1292

  7. The Nature of Progression in Parkinson's Disease: An Application of Non-Linear, Multivariate, Longitudinal Random Effects Modelling

    PLoS ONE, Vol. 8, Núm. 10

2012

  1. Duodenal levodopa/carbidopa infusion therapy in patients with advanced Parkinson's disease leads to improvement in caregivers' stress and burden

    European Journal of Neurology, Vol. 19, Núm. 9, pp. 1261-1265

  2. Frontostriatal cognitive staging in Parkinson's disease

    Parkinson's Disease

  3. Is DaTSCAN really needed for accurate Parkinson's disease diagnosis?

    Expert Review of Neurotherapeutics

  4. Levodopa dosage determines adherence to long-acting dopamine agonists in Parkinson's disease

    Journal of the Neurological Sciences, Vol. 318, Núm. 1-2, pp. 90-93

  5. Long-term exposure to duodenal levodopa/carbidopa infusion therapy improves quality of life in relation especially to mobility, activities of daily living, and emotional well-being

    Acta Neurologica Scandinavica, Vol. 125, Núm. 3, pp. 187-191

  6. Parkinson’s disease: Where are we?

    Parkinson's Disease, Second Edition (CRC Press), pp. 21-27

  7. Placebo effect in Parkinson’s disease

    Parkinson's Disease, Second Edition (CRC Press), pp. 803-810